Benzinga Pro Headlines
Headlines
Piper Sandler Maintains Neutral on Dollar General, Raises Price Target to $129
Piper Sandler analyst Peter Keith maintains Dollar General (NYSE:DG) with a Neutral and raises the price target from $117 to $129.
Watching BrightSpring Health Services; Hearing Investor Business Daily SwingTrader Buys Stock
Evercore ISI Group Maintains Outperform on Ulta Beauty, Raises Price Target to $660
Evercore ISI Group analyst Michael Binetti maintains Ulta Beauty (NASDAQ:ULTA) with a Outperform and raises the price target from $640 to $660.
Evercore ISI Group Maintains In-Line on T. Rowe Price Group, Lowers Price Target to $115
Evercore ISI Group analyst Glenn Schorr maintains T. Rowe Price Group (NASDAQ:TROW) with a In-Line and lowers the price target from $118 to $115.
UBS Maintains Neutral on Kroger, Lowers Price Target to $70
UBS analyst Michael Lasser maintains Kroger (NYSE:KR) with a Neutral and lowers the price target from $74 to $70.
UBS Maintains Sell on National Beverage, Lowers Price Target to $35
UBS analyst Peter Grom maintains National Beverage (NASDAQ:FIZZ) with a Sell and lowers the price target from $39 to $35.
UBS Maintains Neutral on Docusign, Lowers Price Target to $75
UBS analyst Karl Keirstead maintains Docusign (NASDAQ:DOCU) with a Neutral and lowers the price target from $85 to $75.
Evercore ISI Group Maintains In-Line on Macy's, Raises Price Target to $21
Evercore ISI Group analyst Michael Binetti maintains Macy's (NYSE:M) with a In-Line and raises the price target from $14 to $21.
UBS Maintains Buy on Ulta Beauty, Raises Price Target to $690
UBS analyst Michael Lasser maintains Ulta Beauty (NASDAQ:ULTA) with a Buy and raises the price target from $680 to $690.
Evercore ISI Group Maintains Outperform on Kroger, Lowers Price Target to $77
Evercore ISI Group analyst Michael Montani maintains Kroger (NYSE:KR) with a Outperform and lowers the price target from $80 to $77.
UBS Maintains Buy on Omnicom Group, Raises Price Target to $108
UBS analyst Adam Berlin maintains Omnicom Group (NYSE:OMC) with a Buy and raises the price target from $99 to $108.
UBS Maintains Neutral on Edwards Lifesciences, Raises Price Target to $92
UBS analyst Danielle Antalffy maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $90 to $92.
Evercore ISI Group Maintains In-Line on Docusign, Lowers Price Target to $80
Evercore ISI Group analyst Kirk Materne maintains Docusign (NASDAQ:DOCU) with a In-Line and lowers the price target from $92 to $80.
Evercore ISI Group Maintains In-Line on Dollar General, Raises Price Target to $130
Evercore ISI Group analyst Michael Montani maintains Dollar General (NYSE:DG) with a In-Line and raises the price target from $105 to $130.
UBS Maintains Buy on Dollar General, Raises Price Target to $143
UBS analyst Michael Lasser maintains Dollar General (NYSE:DG) with a Buy and raises the price target from $135 to $143.
UBS Maintains Buy on Brookfield Renewable, Raises Price Target to $39
UBS analyst William Grippin maintains Brookfield Renewable (NYSE:BEP) with a Buy and raises the price target from $38 to $39.
Twin Hospitality Group Shares Halted On Circuit Breaker To The Downside, Stock Now Up 19.30%
Wells Fargo Maintains Overweight on Samsara, Raises Price Target to $52
Wells Fargo analyst Michael Turrin maintains Samsara (NYSE:IOT) with a Overweight and raises the price target from $50 to $52.
SMX (Security Matters) Shares Halted On Circuit Breaker To The Downside, Stock Now Up 173.94%
Wells Fargo Maintains Equal-Weight on Docusign, Lowers Price Target to $75
Wells Fargo analyst Michael Turrin maintains Docusign (NASDAQ:DOCU) with a Equal-Weight and lowers the price target from $85 to $75.
Wells Fargo Maintains Underweight on FactSet Research Systems, Lowers Price Target to $260
Wells Fargo analyst Jason Haas maintains FactSet Research Systems (NYSE:FDS) with a Underweight and lowers the price target from $296 to $260.
Wells Fargo Maintains Equal-Weight on Cooper Companies, Raises Price Target to $82
Wells Fargo analyst Larry Biegelsen maintains Cooper Companies (NASDAQ:COO) with a Equal-Weight and raises the price target from $72 to $82.
Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $96
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $95 to $96.
Evercore ISI Group Maintains In-Line on Brown-Forman, Raises Price Target to $32
Evercore ISI Group analyst Robert Ottenstein maintains Brown-Forman (NYSE:BF) with a In-Line and raises the price target from $30 to $32.
Wells Fargo Maintains Underweight on Baldwin Insurance, Raises Price Target to $25
Wells Fargo analyst Elyse Greenspan maintains Baldwin Insurance (NASDAQ:BWIN) with a Underweight and raises the price target from $24 to $25.
Evercore ISI Group Maintains Outperform on AllianceBernstein Holding, Raises Price Target to $46
Evercore ISI Group analyst John Dunn maintains AllianceBernstein Holding (NYSE:AB) with a Outperform and raises the price target from $44 to $46.
Wells Fargo Maintains Overweight on Arthur J. Gallagher, Lowers Price Target to $344
Wells Fargo analyst Elyse Greenspan maintains Arthur J. Gallagher (NYSE:AJG) with a Overweight and lowers the price target from $362 to $344.
Wells Fargo Maintains Overweight on SLM, Raises Price Target to $35
Wells Fargo analyst Donald Fandetti maintains SLM (NASDAQ:SLM) with a Overweight and raises the price target from $33 to $35.
'DOT Selects Winner In Overhaul Of Air Traffic Control System; Virginia-based Peraton Won The Competition To Oversee The Modernization Of Aging Technology And Infrastructure.'
Wells Fargo Maintains Overweight on Kroger, Lowers Price Target to $70
Wells Fargo analyst Edward Kelly maintains Kroger (NYSE:KR) with a Overweight and lowers the price target from $78 to $70.
Wells Fargo Maintains Equal-Weight on Genius Sports, Raises Price Target to $13
Wells Fargo analyst Trey Bowers maintains Genius Sports (NYSE:GENI) with a Equal-Weight and raises the price target from $10 to $13.
Wells Fargo Maintains Equal-Weight on PVH, Lowers Price Target to $85
Wells Fargo analyst Ike Boruchow maintains PVH (NYSE:PVH) with a Equal-Weight and lowers the price target from $88 to $85.
Truist Securities Maintains Hold on Genesco, Lowers Price Target to $27
Truist Securities analyst Joseph Civello maintains Genesco (NYSE:GCO) with a Hold and lowers the price target from $31 to $27.
Reuters: Swiss Government Prepares To Water Down Part Of UBS Capital Rules, Preparing To Soften Rules It Has Control Over
JP Morgan Maintains Neutral on Mosaic, Lowers Price Target to $24
JP Morgan analyst Jeffrey Zekaukas maintains Mosaic (NYSE:MOS) with a Neutral and lowers the price target from $26 to $24.
JP Morgan Maintains Neutral on SentinelOne, Lowers Price Target to $17
JP Morgan analyst Brian Essex maintains SentinelOne (NYSE:S) with a Neutral and lowers the price target from $19 to $17.
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $92
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $90 to $92.
JP Morgan Maintains Overweight on Reliance, Lowers Price Target to $340
JP Morgan analyst Bennett Moore maintains Reliance (NYSE:RS) with a Overweight and lowers the price target from $345 to $340.
Truist Securities Maintains Hold on Dollar General, Raises Price Target to $129
Truist Securities analyst Scot Ciccarelli maintains Dollar General (NYSE:DG) with a Hold and raises the price target from $120 to $129.
JP Morgan Maintains Neutral on Kroger, Lowers Price Target to $71
JP Morgan analyst Thomas Palmer maintains Kroger (NYSE:KR) with a Neutral and lowers the price target from $73 to $71.
Truist Securities Maintains Buy on Parsons, Lowers Price Target to $90
Truist Securities analyst Tobey Sommer maintains Parsons (NYSE:PSN) with a Buy and lowers the price target from $100 to $90.
JP Morgan Maintains Neutral on International Paper, Lowers Price Target to $46
JP Morgan analyst Detlef Winckelmann maintains International Paper (NYSE:IP) with a Neutral and lowers the price target from $48 to $46.
JP Morgan Maintains Neutral on Docusign, Lowers Price Target to $78
JP Morgan analyst Mark Murphy maintains Docusign (NASDAQ:DOCU) with a Neutral and lowers the price target from $80 to $78.
JP Morgan Maintains Underweight on Brown-Forman, Lowers Price Target to $28
JP Morgan analyst Drew Levine maintains Brown-Forman (NYSE:BF) with a Underweight and lowers the price target from $29 to $28.
CDC Prevention Advisory Committee On Immunization Practices Voted To Abandon Universal Hepatitis B Vaccination For Newborns
https://www.cnn.com/health/live-news/cdc-vaccine-meeting-hepatitis-b-12-05-25
JP Morgan Maintains Neutral on Cooper Companies, Raises Price Target to $78
JP Morgan analyst Robbie Marcus maintains Cooper Companies (NASDAQ:COO) with a Neutral and raises the price target from $66 to $78.
JP Morgan Maintains Neutral on Teck Resources, Raises Price Target to C$72
JP Morgan analyst Bill Peterson maintains Teck Resources (TSX:TECK) with a Neutral and raises the price target from C$60 to C$72.
JP Morgan Maintains Neutral on Teck Resources, Raises Price Target to $51
JP Morgan analyst Bill Peterson maintains Teck Resources (NYSE:TECK) with a Neutral and raises the price target from $43 to $51.
JP Morgan Maintains Neutral on Steel Dynamics, Raises Price Target to $190
JP Morgan analyst Bill Peterson maintains Steel Dynamics (NASDAQ:STLD) with a Neutral and raises the price target from $165 to $190.
Morgan Stanley Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $564
Morgan Stanley analyst Terence Flynn maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price target from $516 to $564.
Gelteq Announces Preclinical Findings Demonstrative Oral Delivery Of Oil-Soluble And Poorly Soluble Drugs Using Co's Gel-Based Platform
JP Morgan Maintains Neutral on Science Applications Intl, Raises Price Target to $125
JP Morgan analyst Seth Seifman maintains Science Applications Intl (NASDAQ:SAIC) with a Neutral and raises the price target from $115 to $125.
Morgan Stanley Maintains Equal-Weight on Dollar General, Raises Price Target to $135
Morgan Stanley analyst Simeon Gutman maintains Dollar General (NYSE:DG) with a Equal-Weight and raises the price target from $125 to $135.
JP Morgan Maintains Neutral on Samsara, Raises Price Target to $48
JP Morgan analyst Alexei Gogolev maintains Samsara (NYSE:IOT) with a Neutral and raises the price target from $46 to $48.
Morgan Stanley Maintains Equal-Weight on The Campbell's, Lowers Price Target to $30
Morgan Stanley analyst Megan Alexander maintains The Campbell's (NASDAQ:CPB) with a Equal-Weight and lowers the price target from $33 to $30.
SoftBank In Talks To Buy Data-Center Investor DigitalBridge - Bloomberg
JP Morgan Maintains Overweight on Pegasystems, Raises Price Target to $74
JP Morgan analyst Alexei Gogolev maintains Pegasystems (NASDAQ:PEGA) with a Overweight and raises the price target from $65 to $74.
Morgan Stanley Maintains Equal-Weight on SentinelOne, Lowers Price Target to $18
Morgan Stanley analyst Hamza Fodderwala maintains SentinelOne (NYSE:S) with a Equal-Weight and lowers the price target from $20 to $18.
JP Morgan Maintains Overweight on Packaging Corp of America, Raises Price Target to $245
JP Morgan analyst Detlef Winckelmann maintains Packaging Corp of America (NYSE:PKG) with a Overweight and raises the price target from $238 to $245.
Morgan Stanley Maintains Equal-Weight on ServiceTitan, Raises Price Target to $125
Morgan Stanley analyst Josh Baer maintains ServiceTitan (NASDAQ:TTAN) with a Equal-Weight and raises the price target from $118 to $125.
JP Morgan Maintains Overweight on Nucor, Raises Price Target to $200
JP Morgan analyst Bill Peterson maintains Nucor (NYSE:NUE) with a Overweight and raises the price target from $175 to $200.
Morgan Stanley Initiates Coverage On BridgeBio Oncology with Overweight Rating, Announces Price Target of $20
Morgan Stanley analyst Sean Laaman initiates coverage on BridgeBio Oncology (NASDAQ:BBOT) with a Overweight rating and announces Price Target of $20.
JP Morgan Maintains Overweight on Hormel Foods, Raises Price Target to $28
JP Morgan analyst Thomas Palmer maintains Hormel Foods (NYSE:HRL) with a Overweight and raises the price target from $27 to $28.
JP Morgan Maintains Overweight on Freeport-McMoRan, Raises Price Target to $58
JP Morgan analyst Bill Peterson maintains Freeport-McMoRan (NYSE:FCX) with a Overweight and raises the price target from $50 to $58.
JP Morgan Maintains Neutral on Alcoa, Raises Price Target to $45
JP Morgan analyst Bill Peterson maintains Alcoa (NYSE:AA) with a Neutral and raises the price target from $35 to $45.
Rothschild & Co Initiates Coverage On Balchem with Neutral Rating, Announces Price Target of $162
Rothschild & Co analyst Artem Chubarov initiates coverage on Balchem (NASDAQ:BCPC) with a Neutral rating and announces Price Target of $162.
William Blair Upgrades Rubrik to Outperform
William Blair analyst Jason Ader upgrades Rubrik (NYSE:RBRK) from Market Perform to Outperform.
Scotiabank Downgrades Mid-America Apartment to Sector Perform, Lowers Price Target to $142
Scotiabank analyst Nicholas Yulico downgrades Mid-America Apartment (NYSE:MAA) from Sector Outperform to Sector Perform and lowers the price target from $146 to $142.
Scotiabank Initiates Coverage On Teva Pharmaceutical Indus with Sector Outperform Rating, Announces Price Target of $35
Scotiabank analyst Louise Chen initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA) with a Sector Outperform rating and announces Price Target of $35.
USA PCE price index (MoM) For Sept 0.3% Vs 0.3% Est.
US PCE Price index (YoY) (Sep) +2.8% vs +2.8% Est.
USA Core PCE Price Index (MoM) For Sept 0.2% Vs 0.2% Est.
Michigan Consumer Sentiment For Dec x53.3 Vs 51.0 Prior
US Core PCE Price Index (YoY) (Sep) +2.8% vs +2.9% Est.
RBC Capital Maintains Sector Perform on National Bank of Canada, Raises Price Target to C$163
RBC Capital analyst Darko Mihelic maintains National Bank of Canada (TSX:NA) with a Sector Perform and raises the price target from C$149 to C$163.
Lake Street Downgrades Argan to Hold, Raises Price Target to $325
Lake Street analyst Robert Brown downgrades Argan (NYSE:AGX) from Buy to Hold and raises the price target from $260 to $325.
Barclays Downgrades American International Gr to Equal-Weight, Lowers Price Target to $88
Barclays analyst Alex Scott downgrades American International Gr (NYSE:AIG) from Overweight to Equal-Weight and lowers the price target from $95 to $88.
Barclays Upgrades Rollins to Overweight, Raises Price Target to $72
Barclays analyst Manav Patnaik upgrades Rollins (NYSE:ROL) from Equal-Weight to Overweight and raises the price target from $60 to $72.
Truist Securities Maintains Buy on Alphabet, Raises Price Target to $350
Truist Securities analyst Youssef Squali maintains Alphabet (NASDAQ:GOOGL) with a Buy and raises the price target from $320 to $350.
Johnson Rice Downgrades ConocoPhillips to Hold, Lowers Price Target to $105
Johnson Rice analyst Charles Meade downgrades ConocoPhillips (NYSE:COP) from Accumulate to Hold and lowers the price target from $108 to $105.
Truist Securities Initiates Coverage On Trinet Group with Hold Rating, Announces Price Target of $62
Truist Securities analyst Tobey Sommer initiates coverage on Trinet Group (NYSE:TNET) with a Hold rating and announces Price Target of $62.
Johnson Rice Upgrades Diversified Energy to Buy, Raises Price Target to $23
Johnson Rice analyst Charles Meade upgrades Diversified Energy (NYSE:DEC) from Accumulate to Buy and raises the price target from $19 to $23.
Pivotal Research Maintains Buy on Alphabet, Raises Price Target to $400
Pivotal Research analyst Jeffrey Wlodarczak maintains Alphabet (NASDAQ:GOOG) with a Buy and raises the price target from $350 to $400.
RBC Capital Maintains Sector Perform on Headwater Exploration, Raises Price Target to C$10
RBC Capital analyst Michael Harvey maintains Headwater Exploration (TSX:HWX) with a Sector Perform and raises the price target from C$9 to C$10.
Mizuho Maintains Neutral on Public Storage, Lowers Price Target to $285
Mizuho analyst Ravi Vaidya maintains Public Storage (NYSE:PSA) with a Neutral and lowers the price target from $310 to $285.
President Donald Trump On Social Meida Posted "I have just approved TINY CARS to be built in America." And "They can be propelled by gasoline, electric, or hybrid."
https://truthsocial.com/@realDonaldTrump/posts/115667445871563304
RBC Capital Maintains Outperform on BRP, Raises Price Target to C$131
RBC Capital analyst Sabahat Khan maintains BRP (TSX:DOO) with a Outperform and raises the price target from C$107 to C$131.
Mizuho Maintains Neutral on National Storage, Lowers Price Target to $30
Mizuho analyst Ravi Vaidya maintains National Storage (NYSE:NSA) with a Neutral and lowers the price target from $34 to $30.
RBC Capital Maintains Outperform on BRP, Raises Price Target to $131
RBC Capital analyst Sabahat Khan maintains BRP (NASDAQ:DOOO) with a Outperform and raises the price target from $107 to $131.
Mizuho Maintains Outperform on Extra Space Storage, Lowers Price Target to $137
Mizuho analyst Ravi Vaidya maintains Extra Space Storage (NYSE:EXR) with a Outperform and lowers the price target from $154 to $137.
Johnson Rice Upgrades APA to Accumulate, Raises Price Target to $40
Johnson Rice analyst Charles Meade upgrades APA (NASDAQ:APA) from Hold to Accumulate and raises the price target from $35 to $40.
RBC Capital Upgrades Extendicare to Outperform, Raises Price Target to C$25
RBC Capital analyst Pammi Bir upgrades Extendicare (TSX:EXE) from Sector Perform to Outperform and raises the price target from C$15 to C$25.
JP Morgan Downgrades TotalEnergies to Neutral
JP Morgan analyst Matthew Lofting downgrades TotalEnergies (NYSE:TTE) from Overweight to Neutral.
Mizuho Maintains Neutral on CubeSmart, Lowers Price Target to $38
Mizuho analyst Ravi Vaidya maintains CubeSmart (NYSE:CUBE) with a Neutral and lowers the price target from $43 to $38.
Mizuho Maintains Outperform on Cooper Companies, Raises Price Target to $100
Mizuho analyst Anthony Petrone maintains Cooper Companies (NASDAQ:COO) with a Outperform and raises the price target from $85 to $100.
RBC Capital Maintains Outperform on Samsara, Raises Price Target to $50
RBC Capital analyst Matthew Hedberg maintains Samsara (NYSE:IOT) with a Outperform and raises the price target from $46 to $50.
JP Morgan Upgrades Commercial Metals to Overweight, Raises Price Target to $78
JP Morgan analyst Bill Peterson upgrades Commercial Metals (NYSE:CMC) from Neutral to Overweight and raises the price target from $64 to $78.
RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $95 to $100.
RBC Capital Reiterates Sector Perform on Docusign, Maintains $95 Price Target
RBC Capital analyst Rishi Jaluria reiterates Docusign (NASDAQ:DOCU) with a Sector Perform and maintains $95 price target.